Heart health study for adults getting certain chemo
Part of Cancer, Heart & circulation, Injuries & trauma clinical trials.
This study tracks the heart health of adults receiving chemotherapy that may affect the heart. It helps doctors understand how to better monitor and protect patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are receiving or have received chemotherapy that can affect the heart
- You had a heart checkup (ECG and echocardiogram) at the start of treatment and at least one follow-up visit
- You are able to have follow-up information collected either during a medical visit or by phone
- You are willing to sign a consent form to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how targeted cancer treatments affect the heart. If you are an adult with any type of cancer and are getting or will get chemotherapy (including targeted drugs), joining this study helps doctors understand heart risks better.
This study helps doctors predict which cancer patients are at higher risk of heart problems from their cancer treatments. By tracking your heart health before, during, and after treatment, researchers can develop better ways to protect your heart.
This study looks at how cancer therapies affect the heart health of children. It aims to find heart problems early using special tests, so doctors can help prevent damage.
This study watches how chemotherapy and HER2-targeted drugs affect your heart during early-stage breast cancer treatment. Researchers use heart scans to catch any changes early and understand how to protect heart health.
This study checks how a common chemotherapy drug (anthracycline) affects the heart in children. It will monitor heart function during treatment to help protect young patients.
This study tests a method to predict and warn about heart damage from a common type of breast cancer chemotherapy. If you have HER2-positive breast cancer and will receive anthracycline drugs, this trial may help monitor your heart health.
Hear when a new Cardiac Toxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.